Switch to:
More From Other Websites
[$$] Bristol-Myers Squibb misses mark with cancer drug Aug 30 2016
Healthcare's best bets following generic EpiPen Aug 29 2016
Time to Shift Your Focus Aug 28 2016
Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo Aug 25 2016
Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo Aug 25 2016
How Did Bristol-Myers Squibb Fare in 2Q16? Aug 24 2016
Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016 Aug 23 2016
Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016 Aug 23 2016
Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016 Aug 23 2016
Allied Minds, Bristol-Myers Squibb to progress first drug to preclinical trials Aug 22 2016
How Did Bristol-Myers Squibb’s Oncology Segment Perform in 2Q16? Aug 22 2016
Bristol-Myers Squibb Stock Will Bounce Back -- Here's How You Can Profit Aug 22 2016
[$$] The Profit and Peril of Cancer Drugs Aug 21 2016
5 Trade Ideas for Monday: Bank of America, Bristol-Myers, DuPont, Halliburton and Mylan Aug 21 2016
Curbing Excessive Exuberance May be Premature Aug 21 2016
How Does Bristol-Myers Squibb’s Valuation Compare to Peers? Aug 19 2016
[$$] The Profit and Peril of Cancer Drugs Aug 19 2016
ETF’s with exposure to Bristol-Myers Squibb Co. : August 19, 2016 Aug 19 2016
Bristol-Myers Squibb attracts upside bets Aug 17 2016
Mirror Image: Bristol-Myers Loss Is Merck's Potential Gain Aug 16 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK